AS-101

N/A

Report date: 2025/07/01 20:00:14
NME

Base Information

Drug NameAS-101
Drug Alias NameOssireneWAX-120337IVAX-Q-101IVX-Q-101CB-06-02 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonistsIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-4/beta-1Integrin alpha-V/beta-3
Therapy Area/IndicationsPsoriasisAlopeciaDermatitis, Atopic +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiomas Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFeramda LtdAmerican Friends Of Rabin Medical Center IncBiomas Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsPsoriasisAlopeciaDermatitis, Atopic +[10] 

Other Information

ATC CodeN/A
Related LinksN/A